As of Feb 28, 2025
Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC)
Ticker | Name | Share % | |
---|---|---|---|
RNA | Avidity Biosciences Inc | 2.84% | |
SMMT | Summit Therapeutics Inccommon Stock | 1.11% | |
VKTX | Viking Therapeutics Inc Com | 2.75% | |
CGEM | Cullinan Oncology Inc | 2.34% | |
DYN | Dyne Therapeutics Inc | 2.29% | |
NVAX | Novavax Inc | 2.24% | |
VERA | Vera Therapeutics Inc Ser C Pc Pp | 2.19% | |
SYRE | Spyre Therapeutics Inc | 0.76% | |
MRUS | Merus Nv | 1.13% | |
ACLX | Arcellx, Inc. | 1.36% | |
BLTE | Belite Bio, Inc | 1.09% | |
SLRN | Acelyrin Inc | 0.90% | |
NAMS | Newamsterdam Pharma Company Nv | 0.88% | |
MLYS | Mineralys Therapeutics Inc | 0.87% | |
NMRA | Neumora Therapeu | 0.86% | |
GPCR | Structure Therapeutics Inc ADR USD.0001 | 0.55% | |
NGNE | Neurogene Inc - Series B | 0.52% | |
PRME | Prime Medicine, Inc. | 0.36% | |
AKRO | Akero Therapeutics Inc | 1.57% | |
LQDA | Liquidia Corp. | 1.43% | |
SANA | Sana Biotechnology Inc | 1.26% | |
ARQT | Arcutis Biotherapeutics Inc | 1.22% | |
ANAB | Anaptysbio Inc | 1.13% | |
XERS | Xeris Biopharma Holdings Inc | 1.12% | |
VIR | Vir Biotechnology Inc | 1.12% | |
ETNB | 89bio Inc | 1.11% |
The BBC ETF is currently trading at $19.80, which represents a 2.27% change. Over the past 52 weeks, the ETF has traded as high as $31.65 and as low as $18.77.
The expense ratio of BBC is 0.79%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for BBC is 15.49M. This represents the total market value of the assets managed by the ETF.
BBC follows a Small Cap Growth investment style.
The top holdings of BBC include: RNA (2.84%), SMMT (1.11%), VKTX (2.75%), CGEM (2.34%), DYN (2.29%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BBC is currently not available.